UBE2I and prostate carcinoma: A comprehensive study reported an increase in UBC9 expression in primary colon and prostate cancer compared with their normal tissue counterparts, whereas UBC9 levels were found lower in metastatic breast, prostate, and lung cancer in comparison with their corresponding normal and primary adenocarcinoma tissues (Moschos et al., 2010).